{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:50Z","timestamp":1786119290692,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/hco.0b013e32832b40e1","type":"journal-article","created":{"date-parts":[[2009,6,8]],"date-time":"2009-06-08T03:18:51Z","timestamp":1244431131000},"page":"279-287","source":"Crossref","is-referenced-by-count":3,"title":["Clinical trials in heart valve disease"],"prefix":"10.1097","volume":"24","author":[{"given":"Ralph AH","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","first-page":"e523","article-title":"2008 Focused Update Incorporated Into the ACC\/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: a Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) \u2013 endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"118","author":"Bonow","year":"2008","journal-title":"Circulation"},{"key":"R2-4-20210204","first-page":"230","article-title":"Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology","volume":"28","author":"Vahanian","year":"2007","journal-title":"Eur Heart J"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1161\/hc4301.098249","article-title":"Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis","volume":"104","author":"Novaro","year":"2001","journal-title":"Circulation"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","article-title":"Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis","volume":"110","author":"Rosenhek","year":"2004","journal-title":"Circulation"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J Med"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","volume":"114","author":"Ng","year":"2004","journal-title":"J Clin Invest"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","article-title":"Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome","volume":"154","author":"Lacro","year":"2007","journal-title":"Am Heart J"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/S0735-1097(98)00454-9","article-title":"ACC\/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease)","volume":"32","author":"Bonow","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ahj.2007.01.006","article-title":"Vasodilator therapy in patients with aortic insufficiency: a systematic review","volume":"153","author":"Mahajerin","year":"2007","journal-title":"Am Heart J"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa050666","article-title":"Long-term vasodilator therapy in patients with severe aortic regurgitation","volume":"353","author":"Evangelista","year":"2005","journal-title":"N Engl J Med"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM199409153311101","article-title":"Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function","volume":"331","author":"Scognamiglio","year":"1994","journal-title":"N Engl J Med"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1172\/JCI117277","article-title":"Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation","volume":"93","author":"Tsutsui","year":"1994","journal-title":"J Clin Invest"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/CIRCULATIONAHA.108.770438","article-title":"Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease","volume":"118","author":"Stewart","year":"2008","journal-title":"Circulation"},{"key":"R16-4-20210204","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ahj.2004.06.030","article-title":"A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications","volume":"149","author":"Ahmed","year":"2005","journal-title":"Am Heart J"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1016\/j.ahj.2003.10.017","article-title":"Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS)","volume":"147","author":"Chockalingam","year":"2004","journal-title":"Am Heart J"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R20-4-20210204","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ahj.2008.03.012","article-title":"A randomized trial of the aldosterone receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis","volume":"156","author":"Stewart","year":"2008","journal-title":"Am Heart J"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0022-5223(95)70243-1","article-title":"Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials","volume":"110","author":"Pouleur","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R22-4-20210204","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-5223(19)40105-0","article-title":"Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves","volume":"72","author":"Altman","year":"1976","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-8703(77)80351-7","article-title":"Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves","volume":"94","author":"Dale","year":"1977","journal-title":"Am Heart J"},{"key":"R24-4-20210204","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N Engl J Med"},{"key":"R25-4-20210204","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0735-1097(99)00598-7","article-title":"Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study","volume":"35","author":"Laffort","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R26-4-20210204","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0002-9149(83)90673-2","article-title":"Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole","volume":"51","author":"Chesebro","year":"1983","journal-title":"Am J Cardiol"},{"key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-5223(97)70264-2","article-title":"Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves","volume":"113","author":"Meschengieser","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R28-4-20210204","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(88)92070-3","article-title":"Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement","volume":"1","author":"Turpie","year":"1988","journal-title":"Lancet"},{"key":"R29-4-20210204","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-5223(19)36724-8","article-title":"Comparison of two levels of anticoagulant therapy in patients with substitute heart valves","volume":"101","author":"Altman","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R30-4-20210204","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJM199002153220703","article-title":"Trial of different intensities of anticoagulation in patients with prosthetic heart valves","volume":"322","author":"Saour","year":"1990","journal-title":"N Engl J Med"},{"key":"R31-4-20210204","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.94.9.2107","article-title":"AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves","volume":"94","author":"Acar","year":"1996","journal-title":"Circulation"},{"key":"R32-4-20210204","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/eurheartj\/ehm391","article-title":"Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II","volume":"28","author":"Koertke","year":"2007","journal-title":"Eur Heart J"},{"key":"R34-4-20210204","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.STR.0000149621.95215.ea","article-title":"Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials","volume":"36","author":"Leonardi-Bee","year":"2005","journal-title":"Stroke"},{"key":"R35-4-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","article-title":"Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials","volume":"167","author":"Dentali","year":"2007","journal-title":"Arch Intern Med"},{"key":"R36-4-20210204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","article-title":"Optimal oral anticoagulant therapy in patients with mechanical heart valves","volume":"333","author":"Cannegieter","year":"1995","journal-title":"N Engl J Med"},{"key":"R37-4-20210204","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/0735-1097(94)90753-6","article-title":"Combined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease","volume":"23","author":"Hayashi","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"R38-4-20210204","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","article-title":"Self-monitoring of oral anticoagulation: a systematic review and meta-analysis","volume":"367","author":"Heneghan","year":"2006","journal-title":"Lancet"},{"key":"R39-4-20210204","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.107.712349","article-title":"A replacement for warfarin: the search continues","volume":"116","author":"Eikelboom","year":"2007","journal-title":"Circulation"},{"key":"R40-4-20210204","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0735-1097(00)00834-2","article-title":"Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial","volume":"36","author":"Hammermeister","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R41-4-20210204","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/heart.89.7.715","article-title":"Twenty year comparison of a Bjork\u2013Shiley mechanical heart valve with porcine bioprostheses","volume":"89","author":"Oxenham","year":"2003","journal-title":"Heart"},{"key":"R42-4-20210204","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/hrt.2007.127506","article-title":"Valve type and long-term outcomes after aortic valve replacement in older patients","volume":"94","author":"Schelbert","year":"2008","journal-title":"Heart"},{"key":"R43-4-20210204","first-page":"80","article-title":"The On-X heart valve: mid-term results in a poorly anticoagulated population","volume":"15","author":"Williams","year":"2006","journal-title":"J Heart Valve Dis"},{"key":"R44-4-20210204","first-page":"131","article-title":"Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial","volume":"8","author":"Schaff","year":"1999","journal-title":"J Heart Valve Dis"},{"key":"R45-4-20210204","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCULATIONAHA.105.582882","article-title":"Percutaneous aortic valve implantation retrograde from the femoral artery","volume":"113","author":"Webb","year":"2006","journal-title":"Circulation"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HCO.0b013e32832b40e1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:54:18Z","timestamp":1786038858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001573-200907000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e32832b40e1","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}